Metzger, O., Mandrekar, S., Goel, S., Gligorov, J., Lim, E., Ciruelos, E., Loibl, S., Dockter, T., Farré, X. G., Francis, P. A., Lynce, F., Lanzillotti, J., DuFrane, C., Wall, A., Strand, C., Krop, I., Vaz-Luis, I., Tripathy, D., Loi, S., Prat, A., Goetz, M., Escrivá-de-Romaní, S., Porter, D., Spoenlein, J., Stover, D. G., Sardesai, S., Heudel, P., Koehler, M., Bartlett, C. H., Holynskyj, A., Gopalakrishna, P., Gauthier, E., Delaloge, S., Miller, K., Winer, E. P., Gianni, L., Partridge, A. H., DeMichele, A., Carey, L. A. (2026). Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2511218